Literature DB >> 10565462

A one-year population-based study of drug prescriptions for Danish children.

N Thrane1, H T Sørensen.   

Abstract

We examined the pattern of prescribed drug use in Danish children and used a pharmacoepidemiological prescription database to identify all reimbursed prescriptions for children aged 0-15 y living in North Jutland County (population 95 189), Denmark, during 1997. We identified 154 189 prescriptions for 48 091 drug users. The 20 most frequently prescribed chemical substance subgroups comprised 71.3% of all prescriptions. The mean annual prescription rate was 1621/1000 children/y. Overall, 50.6% of the population received one or more prescription. In children younger than 3 y, 75.3% received prescriptions and 17.5% obtained five or more prescriptions. Systemic antibiotics, anti-asthmatics, ophthalmologicals and dermatological corticosteroids accounted for 82% of prescriptions. One-third of the young children received anti-asthmatics, mainly oral beta-2 agonists, and almost half received antibiotics, mainly broad-spectrum penicillins. In the 7-15-y-olds, 39.1% received prescriptions. Hormones, antihistamines, anti-epileptics, anti-acne preparations and anti-diabetics comprised an increasing proportion of prescriptions. About 20% received antibiotics and 6% anti-asthmatics. In conclusion, the level of exposure to prescribed drugs was considerable at all ages and was highest in early childhood. Our study supports the need for epidemiological studies on the reasons for drug use and evaluation of their pharmacological effects in children.

Entities:  

Mesh:

Year:  1999        PMID: 10565462     DOI: 10.1080/08035259950168216

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  25 in total

1.  Adverse drug reactions reported for systemic antibacterials in Danish children over a decade.

Authors:  Lise Aagaard; Ebba Holme Hansen
Journal:  Br J Clin Pharmacol       Date:  2010-11       Impact factor: 4.335

Review 2.  Study designs in paediatric pharmacoepidemiology.

Authors:  Katia Verhamme; Miriam Sturkenboom
Journal:  Eur J Clin Pharmacol       Date:  2010-11-25       Impact factor: 2.953

3.  Utility of routinely acquired primary care data for paediatric disease epidemiology and pharmacoepidemiology.

Authors:  Peter J Helms; Suzie Ekins Daukes; Michael W Taylor; Colin R Simpson; James S McLay
Journal:  Br J Clin Pharmacol       Date:  2005-06       Impact factor: 4.335

4.  Acute drug prescribing to children on chronic antiepilepsy therapy and the potential for adverse drug interactions in primary care.

Authors:  Philipp H Novak; Suzie Ekins-Daukes; Colin R Simpson; Robert M Milne; Peter Helms; James S McLay
Journal:  Br J Clin Pharmacol       Date:  2005-06       Impact factor: 4.335

Review 5.  Adverse drug reactions associated with asthma medications in children: systematic review of clinical trials.

Authors:  Lise Aagaard; Ebba Holme Hansen
Journal:  Int J Clin Pharm       Date:  2014-02-23

Review 6.  Methods in pharmacoepidemiology: a review of statistical analyses and data reporting in pediatric drug utilization studies.

Authors:  Marco Sequi; Rita Campi; Antonio Clavenna; Maurizio Bonati
Journal:  Eur J Clin Pharmacol       Date:  2012-07-26       Impact factor: 2.953

7.  Drug use of children in the community assessed through pharmacy dispensing data.

Authors:  E Schirm; P van den Berg; H Gebben; P Sauer; L De Jong-van den Berg
Journal:  Br J Clin Pharmacol       Date:  2000-11       Impact factor: 4.335

Review 8.  Antibiotic prescription and prevalence rate in the outpatient paediatric population: analysis of surveys published during 2000-2005.

Authors:  Alessandra Rossignoli; Antonio Clavenna; Maurizio Bonati
Journal:  Eur J Clin Pharmacol       Date:  2007-09-21       Impact factor: 2.953

9.  Adolescents' struggles with swallowing tablets: barriers, strategies and learning.

Authors:  Dana Lee Hansen; Ditte Tulinius; Ebba Holme Hansen
Journal:  Pharm World Sci       Date:  2007-06-27

10.  Adverse drug reactions and off-label drug use in paediatric outpatients.

Authors:  Benjamin Horen; Jean-Louis Montastruc; Maryse Lapeyre-Mestre
Journal:  Br J Clin Pharmacol       Date:  2002-12       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.